2016
DOI: 10.1007/s00264-016-3342-9
|View full text |Cite
|
Sign up to set email alerts
|

Platelet-rich plasma for the treatment of bone defects: from pre-clinical rational to evidence in the clinical practice. A systematic review

Abstract: Overall, the available literature presents major limitations in terms of low quality and extreme heterogeneity, which hamper the possibility to optimize PRP treatment and translate it into a real clinical benefit despite positive preclinical findings on its biological potential to favour bone healing.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
81
0
10

Year Published

2017
2017
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 92 publications
(92 citation statements)
references
References 92 publications
1
81
0
10
Order By: Relevance
“…Platelet-rich-plasma (PRP), represents one of the most cost-effective autologous source of different growth factors and other bio-active proteins that can promote cell attachment, spreading, migration, growth, and differentiation (Boyd, Bradwell, & Thompson, 1993;McFarland, Thomas, DeFilippis, Steele, & Healy, 1999). It has been used in clinical practice for quite some time, such as the treatment of bone defects and ankle cartilage pathology (Roffi, Di Matteo, Krishnakumar, Kon, & Filardo, 2017;Vannini & Filardo, 2015). The platelets in PRP can release a large amount of bioactive factors upon activation, such as adhesive proteins and growth factors, but also clotting factors, derivatives of arachidonic acid metabolism, calcium ions, and others (Davì & Patrono, 2007;Yun, Sim, Goh, Park, & Han, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…Platelet-rich-plasma (PRP), represents one of the most cost-effective autologous source of different growth factors and other bio-active proteins that can promote cell attachment, spreading, migration, growth, and differentiation (Boyd, Bradwell, & Thompson, 1993;McFarland, Thomas, DeFilippis, Steele, & Healy, 1999). It has been used in clinical practice for quite some time, such as the treatment of bone defects and ankle cartilage pathology (Roffi, Di Matteo, Krishnakumar, Kon, & Filardo, 2017;Vannini & Filardo, 2015). The platelets in PRP can release a large amount of bioactive factors upon activation, such as adhesive proteins and growth factors, but also clotting factors, derivatives of arachidonic acid metabolism, calcium ions, and others (Davì & Patrono, 2007;Yun, Sim, Goh, Park, & Han, 2016).…”
Section: Introductionmentioning
confidence: 99%
“…However, these results and this latter conclusion is at least consistent with numerous clinical studies in people that fail to identify a positive effect of PRP on bone healing, even when open fracture gaps and open osteotomies are considered. [7] Rather, further studies should likely be performed in relevant models or human clinical populations in which bone loss, fracture gaps, or delayed union are present so as to optimize the likelihood of identifying a treatment effect.…”
Section: Discussionmentioning
confidence: 99%
“…[8] However, other authors conclude that the evidence remains ambiguous as numerous studies, particularly when considering clinical trials in people, fail to provide consistent or convincing evidence of benefit. [7] Contradictory results from different studies and contradictory conclusions from different reviews preclude making a general conclusion as to whether PRP is likely to augment bone healing.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Platelet-rich plasma is commonly studied pre-clinically, as well as currently used clinically, for repair of bone defects. 128 Dense polyP granules are found in many cell types, particularly within the mitochondria. This includes osteoblasts, where polyP is found in high concentrations (0.5 M in the dense granules in the mitochondria), and osteoclasts, which have a high number of mitochondria.…”
Section: The Curious Role Of Polyphosphatesmentioning
confidence: 99%